News, analysis, data

NIPs up for EZ, flat thru curve, DZ finds, citing ECB distortion

Posted on 8 August 2018

CBPP3-eligible issuers have been forced to pay larger new issue premiums than non-Eurozone peers, while issuers have not had to pay up to go long, DZ analysts have concluded after surveying issuance since 2016, with demand deemed the most influential factor on NIPs...

The page you have requested is available to registered users only.

Please log in to read the rest of this article and view the full site.

Log in

If you have forgotten your password, please enter the e-mail address you entered when registering for the site into the "reset password" box. You will then be sent a new password to enter on the next page, where you will also be given the option of choosing a new, more memorable password.

Reset password

If registering, you will be sent an e-mail confirming your username and password on pressing "register", as well as being taken to the homepage. If you have any problems accessing the site, please follow the link in the mail.


Recent headlines:

October cuts felt in CBPP3, but secondary holds up

Caution advised with market caught twixt US rates and Italy

CBPP3 hits six-month high before monthly APP halving

ING-DiBa 5s show new levels in EUR1.5bn dual-trancher

ING-DiBa 5s, 15s to restart mart in new quarter

Social status boosts first-mover DKB’s Pfandbrief

MMB setback a startling wake up call amid ECB cutback

MMB pulls debut, averts ‘worse failure’, in sign of times

LBP avoids CBPP3 cut pain, but others may need rethink

Skipton euro first convinces with EUR800m-plus book

ECB cuts CBPP3 bid to 10%, ‘unlucky’ DKB first hit

Modest momentum for ASB 7s, Commerz 4s in softer mart

KHFC set for EUR or USD social covered first, DKB imminent

EeMAP seeks ‘activation’ support as green covered hit Munich

‘Novel’ Crédit Agricole fours, 20s duo a healthy sign

Luminor eyes 2019 pan-Baltic covered in funding shift

ING Belgium EUR1bn reaps big book, ASB due next week

Pbb pragmatic on £300m pricing, legwork benefit cited

CBPP3 buying highest since May upon increased supply